Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1987-1-29
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
N
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0190-535X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
13
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
25-9
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:3540866-Clinical Trials as Topic,
pubmed-meshheading:3540866-Drug Evaluation,
pubmed-meshheading:3540866-Ethics, Professional,
pubmed-meshheading:3540866-Humans,
pubmed-meshheading:3540866-Immunization, Passive,
pubmed-meshheading:3540866-Interleukin-2,
pubmed-meshheading:3540866-Killer Cells, Natural,
pubmed-meshheading:3540866-Neoplasms,
pubmed-meshheading:3540866-Nursing Care,
pubmed-meshheading:3540866-Recombinant Proteins
|
| pubmed:articleTitle |
Clinical trials with IL-2.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|